IBO
HEALTHCAREImpact BioMedical, Inc.
What's Moving IBO Today?
No stock-specific AI insight has been generated for IBO yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.54
Fundamentals
Trading
IBO News
4 articles- ImPact Biotech Presents Updated Data from Phase 1 Trial of Padeliporfin VTP in LA-PDAC and Phase 3 ENLIGHTED Trial in LG-UTUC at ASCO 2026GlobeNewswire Inc.·May 30, 2026
- ImPact Biotech Presents Updated Data from Phase 3 ENLIGHTED Trial of Padeliporfin VTP in LG-UTUC at AUA 2026GlobeNewswire Inc.·May 16, 2026
- Impact BioMedical Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing While Continuing Strategic Merger PlansGlobeNewswire Inc.·Apr 3, 2026
- Impact Biomedical Inc (IBO) Announces 3F™ US Patent IssueYahoo Finance·Aug 18, 2025
All 4 articles loaded
Price Data
52-Week Range
$0.54
Fundamentals
Trading
About Impact BioMedical, Inc.
Impact BioMedical, Inc. is an innovative biotechnology company focused on developing groundbreaking therapeutics and technologies to address critical healthcare challenges. Utilizing advanced research methodologies, the firm aims to improve patient outcomes and overall quality of life. With a robust intellectual property portfolio and an emphasis on scientific rigor, Impact BioMedical is well-positioned for growth in the evolving healthcare market. Its extensive product pipeline and strategic collaborations offer attractive investment opportunities for institutional investors interested in the accelerating biopharmaceutical sector.